Follow-Up Study of Children with Precocious Puberty Treated with Cyproterone Acetate
暂无分享,去创建一个
K. Tachibana | Toshiaki Tanaka | A. Tanae | Yadong Cui | Shaw Watanabe | M. Fujimoto | Y. Matsuo | S. Yamasaki
[1] D. Thomas,et al. Multicentre international liver tumour study protocol of the case‐control study on hepatocellular cancer , 1996, Pharmacoepidemiology and Drug Safety.
[2] T. Rabe,et al. Cyproterone Acetate , 1996, Drug safety.
[3] J. Topinka,et al. Accumulation and persistence of DNA adducts of the synthetic steroid cyproterone acetate in rat liver. , 1995, Carcinogenesis.
[4] P. Kasper,et al. In vitro mutagenicity studies on cyproterone acetate using female rat hepatocytes for metabolic activation and as indicator cells. , 1995, Carcinogenesis.
[5] W. Kuhnz,et al. Identification of 3 alpha-hydroxy-cyproterone acetate as a metabolite of cyproterone acetate in the bile of female rats and the potential of this and other already known or putative metabolites to form DNA adducts in vitro. , 1995, Carcinogenesis.
[6] J. Topinka,et al. DNA-damaging activity of the cyproterone acetate analogues chlormadinone acetate and megestrol acetate in rat liver. , 1995, Carcinogenesis.
[7] A. Martelli,et al. DNA repair synthesis and DNA fragmentation in primary cultures of human and rat hepatocytes exposed to cyproterone acetate. , 1995, Carcinogenesis.
[8] T. Rüdiger,et al. Hepatocellular carcinoma after treatment with cyproterone acetate combined with ethinyloestradiol , 1995, The Lancet.
[9] A. Tanae,et al. Three cases of hepatocellular carcinoma among cyproterone users , 1994, The Lancet.
[10] S. Culine,et al. Hepatocellular Carcinoma During Hormonotherapy for Prostatic Cancer , 1994, American journal of clinical oncology.
[11] L. Crinò,et al. Cyproterone acetate: hepatotoxicity and prostatic cancer treatment. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] E. Deml,et al. Initiation of enzyme-altered foci by the synthetic steroid cyproterone acetate in rat liver foci bioassay. , 1993, Carcinogenesis.
[13] J. Topinka,et al. Cyproterone acetate generates DNA adducts in rat liver and in primary rat hepatocyte cultures. , 1993, Carcinogenesis.
[14] H. Greim,et al. Cyproterone acetate induces DNA damage in cultured rat hepatocytes and preferentially stimulates DNA synthesis in gamma-glutamyltranspeptidase-positive cells. , 1992, Carcinogenesis.
[15] R. Catane,et al. Hepatitis due to cyproterone acetate. , 1992, European journal of cancer.
[16] N. Nagasue,et al. Progesterone receptor in hepatocellular carcinoma. Correlation with androgen and estrogen receptors , 1991, Cancer.
[17] B. Parys,et al. Severe hepatocellular dysfunction following cyproterone acetate therapy. , 1991, British journal of urology.
[18] J. Gaer,et al. Hepatocellular carcinoma and treatment with cyproterone acetate. , 1991, British Journal of Urology.
[19] N. Mcintyre,et al. Severe hepatitis caused by cyproterone acetate. , 1990, Gut.
[20] H. Lévesque,et al. FULMINANT HEPATITIS DUE TO CYPROTERONE ACETATE , 1989, The Lancet.
[21] N. Mulder,et al. Hepatocellular damage by cyproterone acetate. , 1986, European journal of cancer & clinical oncology.
[22] P. Johnson,et al. Sex steroid receptor proteins in foetal, adult and malignant human liver tissue. , 1983, British Journal of Cancer.